Q2 2025 EPS Estimates for Green Thumb Industries Inc. (OTC:GTBIF) Increased by Analyst

Green Thumb Industries Inc. (OTC:GTBIF) – Research analysts at Roth Capital raised their Q2 2025 EPS estimates for Green Thumb Industries in a research note issued on Tuesday, August 6th. Roth Capital analyst S. Fortune now anticipates that the company will post earnings per share of $0.11 for the quarter, up from their previous estimate of $0.07.

Separately, Ventum Cap Mkts upgraded shares of Green Thumb Industries to a “strong-buy” rating in a research note on Tuesday.

Green Thumb Industries Trading Down 4.3 %

Shares of OTC GTBIF traded down $0.51 during mid-day trading on Wednesday, reaching $11.25. 268,427 shares of the company traded hands, compared to its average volume of 507,464. Green Thumb Industries has a fifty-two week low of $6.42 and a fifty-two week high of $16.33.

About Green Thumb Industries

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.